ACM
BIIB icon

Argent Capital Management’s Biogen BIIB Stock Holding History

Argent Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,262
Closed -$1.48M – 182
2021
Q2 		$1.48M Sell
4,262
-46,908
-92% -$14.2M 0.05% 105
2021
Q1 		$14.3M Buy
51,170
+15,760
+45% +$4.25M 0.48% 54
2020
Q4 		$8.67M Sell
35,410
-62,150
-64% -$16M 0.31% 59
2020
Q3 		$27.7M Sell
97,560
-2,024
-2% -$565K 1.06% 30
2020
Q2 		$26.6M Sell
99,584
-11,010
-10% -$3.31M 1.11% 31
2020
Q1 		$35M Buy
110,594
+548
+0.5% +$166K 1.65% 22
2019
Q4 		$32.7M Sell
110,046
-3,968
-3% -$1.1M 1.12% 32
2019
Q3 		$26.5M Buy
114,014
+548
+0.5% +$128K 0.99% 32
2019
Q2 		$26.5M Sell
113,466
-9,541
-8% -$2.2M 1.01% 32
2019
Q1 		$29.1M Buy
123,007
+35,853
+41% +$11.3M 1.06% 31
2018
Q4 		$26.2M Sell
87,154
-43,636
-33% -$13.9M 1.32% 23
2018
Q3 		$46.2M Buy
130,790
+2,968
+2% +$1.02M 1.58% 28
2018
Q2 		$37.1M Sell
127,822
-3,405
-3% -$957K 1.34% 30
2018
Q1 		$35.9M Sell
131,227
-1,280
-1% -$397K 1.31% 30
2017
Q4 		$46.1M Buy
132,507
+1,035
+0.8% +$332K 1.59% 24
2017
Q3 		$41.2M Buy
+131,472
New +$38.9M 1.59% 24
2014
Q3 		– Sell
-5,224
Closed -$1.65M – 161
2014
Q2 		$1.65M Hold
5,224
– – 0.09% 112
2014
Q1 		$1.6M Hold
5,224
– – 0.09% 117
2013
Q4 		$1.46M Sell
5,224
-4,201
-45% -$1.09M 0.08% 117
2013
Q3 		$2.27M Sell
9,425
-2,425
-20% -$543K 0.14% 87
2013
Q2 		$2.55M Buy
+11,850
New +$2.53M 0.16% 79

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Argent Capital Management's BIIB Position: Q3 2021 in Review

Argent Capital Management sold out of Biogen (BIIB) in Q3 2021, closing a stake of 4,262 shares — an estimated $1.48M sold.

Argent Capital Management first reported a position in BIIB in Q2 2013 and held it in 21 quarters. The position peaked at $46.2M in Q3 2018. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Argent Capital Management reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • Argent Capital Management sold 4,262 Biogen shares in Q3 2021, an estimated $1.48M.
  • Argent Capital Management first reported a position in Biogen in Q2 2013 and held it in 21 quarters.
  • Argent Capital Management's Biogen position peaked at $46.2M in Q3 2018.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Argent Capital Management's 13F filing for Q3 2021, filed 8 Nov 2021.